Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-25

Clinical Trial Update: Effect of Dapagliflozin on Body Weight in Overweight Women Consuming Different Proportions of Carbohydrate Diet. [Phase 4]

View source ↗

Summary

A Phase 4 trial examined whether dapagliflozin affects body weight in overweight women on varying carbohydrate diets and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FARXIGA (dapagliflozin)

Snippet

Sponsor: Sun Jia | Conditions: Overweight, Carbohydrate | Phase 4 | Status: COMPLETED